Acurx Pharmaceuticals, Inc. Stock Split Ratio
Acurx Pharmaceuticals, Inc. (ACXP) had Stock Split Ratio of 5.00% as of 2025-08-04, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-08-13
- 2025-08-04: Stockholders' Equity Note, Stock Split, Conversion Ratio 5.00%.
- 2021-06-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month 50.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month |
|---|---|---|
| 2025-08-04 | 5.00% 10-Q · filed 2026-08-13 | |
| 2021-06-30 | 50.00% 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B |